Relapse of Pheochromocytoma with Hipertensive Heart Disease Mildly Reduced Left Ventricle Ejection Fraction
DOI:
https://doi.org/10.58344/jws.v2i9.427Keywords:
relapsed pheochromocytoma, hypertensive heart diseaseAbstract
Pheochromocytoma is a tumor originating from the medulla of the adrenal gland. This tumor is rare and is caused by excessive production of catecholamines. There are three classic triads of pheochromocytoma: diaphoresis, palpitations and headaches. Elevated metanephrines and normetanephrine in plasma or urine confirm the diagnosis. At the same time, radiological examination helps in the tumor's location and the presence of local invasion or metastasis. Hypertension is a health problem that is quite dangerous worldwide because it is a significant risk factor for cardiovascular diseases such as heart attack, heart failure, stroke, and kidney disease. Hypertension can cause Hypertensive Heart Disease, which is a significant cause of morbidity and mortality due to cardiovascular disease. This scientific report presents a case study of a 19-year-old woman diagnosed with relapsed pheochromocytoma and hypertensive heart disease with mildly reduced left ventricular ejection fraction. This patient was previously diagnosed at the age of 13 with pheochromocytoma, where the patient experienced symptoms of headache, sweating, especially in the forehead area, trembling hands, and hypertension. Hence, the patient had to be treated. The patient underwent further examination and found a right adrenal tumor, so an adrenalectomy was performed on the patient. Similar complaints appeared again in the patient, and further examination was carried out. Moreover, an increase in plasma metanephrine and normetanephrine levels was found. A CT scan of the abdomen revealed a right adrenal tumor, so this patient underwent another adrenalectomy.
References
Amar, L., Lussey-Lepoutre, C., Lenders, J. W., Djadi-Prat, J., Plouin, P.-F., & Steichen, O. (2016). Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: A systematic review and meta-analysis. Eur J Endocrinol, 175, 135–145.
Drazner, M. H. (2011). The progression of hypertensive heart disease. Circulation, 123(3), 327–334.
Farrugia, F. A., Martikos, G., Tzanetis, P., Charalampopoulos, A., Misiakos, E., Zavras, N., & Sotiropoulos, D. (2017). Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocr Regul, 51(3), 168–181.
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young Jr, W. F. (2014). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 99(6), 1915–1942.
Rachmat, L., Djaja, A. S., & Tantri, A. R. (2016). Feokromositoma: Seri Kasus. Majalah Anestesia Dan Critical Care.
Raman, S. V. (2010). The hypertensive heart: an integrated understanding informed by imaging. Journal of the American College of Cardiology, 55(2), 91–96.
S?nchez-Turcius RA. (2015). Pheochromocytomas?: Diagnosis and treatment. Rev Mex Cardiol.
Venugopal, S., Chhabria, M., & Quartuccio, M. (2020). Recurrence of pheochromocytoma with metastases after resection of primary tumor. Cureus, 12(5).
Yandriani, R., & Karani, Y. (2018). Patogenesis Hipertrofi Ventrikel Kiri. Jurnal Kesehatan Andalas, 7, 159–167.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of World Science
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
